Cargando…
CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus
Hippo signaling controls organ size and tumor progression through a conserved pathway leading to nuclear translocation of the transcriptional effector Yki/Yap/Taz. Most of our understanding of Hippo signaling pertains to its cytoplasmic regulation, but how the pathway is controlled in the nucleus re...
Autores principales: | Cho, Yong Suk, Li, Shuang, Wang, Xiaohui, Zhu, Jian, Zhuo, Shu, Han, Yuhong, Yue, Tao, Yang, Yingzi, Jiang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938674/ https://www.ncbi.nlm.nih.gov/pubmed/31857346 http://dx.doi.org/10.1101/gad.333146.119 |
Ejemplares similares
-
Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View
por: Cho, Yong Suk, et al.
Publicado: (2021) -
Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018) -
Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous
Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014) -
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
por: Isfort, Ilka, et al.
Publicado: (2019) -
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis
por: Wang, Haichuan, et al.
Publicado: (2020)